7 cell signaling technology inc cat no 12827 (Cell Signaling Technology Inc)
93
Structured Review
Cell Signaling Technology Inc
7 cell signaling technology inc cat no 12827
7 Cell Signaling Technology Inc Cat No 12827, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/7+cell+signaling+technology+inc+cat+no+12827/PathScan+Phospho-HER2%2FErbB2+(Tyr1221%2F1222)+Sandwich+ELISA+Kit/pmc12871574-33-107-108
Average 93 stars, based on 49 article reviews
7 Cell Signaling Technology Inc Cat No 12827, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/7+cell+signaling+technology+inc+cat+no+12827/PathScan+Phospho-HER2%2FErbB2+(Tyr1221%2F1222)+Sandwich+ELISA+Kit/pmc12871574-33-107-108
Average 93 stars, based on 49 article reviews
7 cell signaling technology inc cat no 12827 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2-positive breast cancer Article Snippet: Primary antibodies were as follows: Ki-67 (cat. no. ab16667), CD31 (cat. no. ab28364), ALDH1A1 (Abcam; cat. no. ab52492), Bcl-2 (Abcam; cat. no. ab692) and CD44 (all Abcam; cat. no. ab254530); Article Title: Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer. Article Snippet: Primary antibodies were as follows: Ki‐67 (cat. no. ab16667), cd31 (cat. no. ab28364), ALdH1A1 (Abcam; cat. no. ab52492), Bcl‐2 (Abcam; cat. no. ab692) and cd44 (all Abcam; cat. no. ab254530); |